Zantac | CBS News | October 9, 2019 There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled the drugs off shelves, following an FDA...
Zantac | Daily Mail | Nathalie Rahhal | October 9, 2019 GSK sells Zantac in Europe and has issued a worldwide recall of four of its prescription variations Zantac and its generic ranitidine were discovered to contain a cancer-linked forever chemical called NDMA Stores like...
Zantac | Reuters | Saumya Joseph | October 2, 2019 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it found “unacceptable levels” of a cancer-causing impurity in the popular heartburn drug Zantac and its generic versions known chemically as ranitidine. U.S. and European health...
The Japan Times | October 1, 2019 BANGALORE, INDIA – GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a “precaution,” days after the U.S. Food and Drug Administration found “unacceptable” levels of probable cancer-causing impurity in the drug. Zantac,...
Miami Herald | David J. Neal | September 26, 2019 For the second time this week, a drug manufacturer has recalled several lots of Ranitidine for too much NDMA, which laboratory tests have classified as a probable cancer-causing ingredient. But unlike Sandoz’s recall of Ranitidine capsules, Apotex’s...